Stock DNA
Pharmaceuticals & Biotechnology
CAD 130 Million ()
NA (Loss Making)
NA
0.00%
-0.02
-14.58%
3.46
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.83%
0%
-30.83%
6 Months
-1.19%
0%
-1.19%
1 Year
-57.65%
0%
-57.65%
2 Years
12.16%
0%
12.16%
3 Years
196.43%
0%
196.43%
4 Years
245.83%
0%
245.83%
5 Years
232.0%
0%
232.0%
Grown Rogue International, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
98.69%
EBIT Growth (5y)
31.29%
EBIT to Interest (avg)
-0.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.33
Tax Ratio
45.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.09%
ROCE (avg)
4.48%
ROE (avg)
0.57%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.52
EV to EBIT
-20.82
EV to EBITDA
-24.66
EV to Capital Employed
3.58
EV to Sales
3.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-17.21%
ROE (Latest)
-14.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.09%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Change(%)
Net Sales
37.00
0.00
NA
Operating Profit (PBDIT) excl Other Income
-1.00
0.00
NA
Interest
3.30
0.00
NA
Exceptional Items
-9.20
0.00
NA
Consolidate Net Profit
-14.70
0.00
NA
Operating Profit Margin (Excl OI)
-62.80%
0.00%
NA
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Grown Rogue International, Inc. 
Grown Rogue International, Inc.
Pharmaceuticals & Biotechnology
Grown Rogue International Inc, formerly Novicius Corp, is a Canada-based company engaged in the alternative medicine sector. The Company is a vertically-integrated cannabis brand that produces and distributes cannabis products. Grown Rogue International Inc specializes in seed-to-experience products through its indoor and outdoor facilities of more than 80,000 square feet, based in Rogue Valley of Southern Oregon, the United States. The Company’s brand offers: Flower, which comes in bags of different sizes together with matchboxes and rolling papers; Pre-rolls, which are nitrogen sealed; Cartridges, as well as Extracts including shatter, wax, oil and sugar that feature concentrated amounts of compounds like tetrahydrocannabinol (THC) and select terpenes.
Company Coordinates 
Company Details
1 King St W Suite 1505 , TORONTO ON : M5H 1A1
Registrar Details






